Az etopozid kiválthat kaszpázfüggo és független aktív sejthalált: Egy három szakaszos model

Translated title of the contribution: Caspase dependent and independent cell death induced by etoposide: A kinetic model of three phases

R. Mihalik, G. Barna, Uher Frenc, I. Peták, Janet A. Houghton, L. Kópper

Research output: Contribution to journalArticle

Abstract

Etoposide induces DNA damage that signals for various forms of active call death in various eel! types, that frequently differ from each other in morphology, in kinetics and in the molecules involved. Here we show, using a specific caspase inhibitor, that several forms of active death can be discriminated in one model, a lymphoma cell line, exposed to etoposide. IJT58, a human B lymphoma cell line was treated with 10pM etoposide and/or 100 pM Z-VAD-FMK as a general caspase inhibitor, which was given daily. Viability was assessed by trypan blue staining. Cell cycle arid sub-Gl (apoptotic) cell population were measured by flow cytometry after propidium iodide staining. Clonality assay (12 days) was performed in soft agar. HT58 cells exposed to etoposide died by fast apoptosis (at 4 h) dependent on caspase activity but independent of new protein synthesis. More prolonged (3 days) incubation with etoposide resulted in apoptosis, but with a slower rate, that was also sensitive to caspase inhibitor, Z-VAD-FMK. HT58 cells are Fas receptor (FasR) negative, but etoposide treatment induced FasR expression on the first day indicating the possible involvement of FasR mediated signals in cell death. In a third phase (after the 3rd day) a portion of the etoposide treated, Z-VAD-FMK-rescued lymphoma cells died in spite of the presence of fresh caspase inhibitor. The survived cells were arrested in S phase, that may protect cells from engagement to mitotic death in the G2 phase. However, the cells protected by caspase inhibitor against etoposide lost their clonal potential (

Original languageHungarian
Pages (from-to)94-99
Number of pages6
JournalMagyar Onkologia
Volume43
Issue number2
Publication statusPublished - 1999

Fingerprint

Etoposide
Caspases
Cell Death
Caspase Inhibitors
CD95 Antigens
Lymphoma
Apoptosis
Staining and Labeling
Cell Line
Eels
Trypan Blue
Propidium
G2 Phase
S Phase
DNA Damage
Agar
Cell Cycle
Flow Cytometry
Population
benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone

ASJC Scopus subject areas

  • Oncology

Cite this

Az etopozid kiválthat kaszpázfüggo és független aktív sejthalált : Egy három szakaszos model. / Mihalik, R.; Barna, G.; Frenc, Uher; Peták, I.; Houghton, Janet A.; Kópper, L.

In: Magyar Onkologia, Vol. 43, No. 2, 1999, p. 94-99.

Research output: Contribution to journalArticle

@article{392f07c973a84863aed2d2d0fff90b27,
title = "Az etopozid kiv{\'a}lthat kaszp{\'a}zf{\"u}ggo {\'e}s f{\"u}ggetlen akt{\'i}v sejthal{\'a}lt: Egy h{\'a}rom szakaszos model",
abstract = "Etoposide induces DNA damage that signals for various forms of active call death in various eel! types, that frequently differ from each other in morphology, in kinetics and in the molecules involved. Here we show, using a specific caspase inhibitor, that several forms of active death can be discriminated in one model, a lymphoma cell line, exposed to etoposide. IJT58, a human B lymphoma cell line was treated with 10pM etoposide and/or 100 pM Z-VAD-FMK as a general caspase inhibitor, which was given daily. Viability was assessed by trypan blue staining. Cell cycle arid sub-Gl (apoptotic) cell population were measured by flow cytometry after propidium iodide staining. Clonality assay (12 days) was performed in soft agar. HT58 cells exposed to etoposide died by fast apoptosis (at 4 h) dependent on caspase activity but independent of new protein synthesis. More prolonged (3 days) incubation with etoposide resulted in apoptosis, but with a slower rate, that was also sensitive to caspase inhibitor, Z-VAD-FMK. HT58 cells are Fas receptor (FasR) negative, but etoposide treatment induced FasR expression on the first day indicating the possible involvement of FasR mediated signals in cell death. In a third phase (after the 3rd day) a portion of the etoposide treated, Z-VAD-FMK-rescued lymphoma cells died in spite of the presence of fresh caspase inhibitor. The survived cells were arrested in S phase, that may protect cells from engagement to mitotic death in the G2 phase. However, the cells protected by caspase inhibitor against etoposide lost their clonal potential (",
author = "R. Mihalik and G. Barna and Uher Frenc and I. Pet{\'a}k and Houghton, {Janet A.} and L. K{\'o}pper",
year = "1999",
language = "Hungarian",
volume = "43",
pages = "94--99",
journal = "Magyar Onkologia",
issn = "0025-0244",
publisher = "Akademiai Kiado",
number = "2",

}

TY - JOUR

T1 - Az etopozid kiválthat kaszpázfüggo és független aktív sejthalált

T2 - Egy három szakaszos model

AU - Mihalik, R.

AU - Barna, G.

AU - Frenc, Uher

AU - Peták, I.

AU - Houghton, Janet A.

AU - Kópper, L.

PY - 1999

Y1 - 1999

N2 - Etoposide induces DNA damage that signals for various forms of active call death in various eel! types, that frequently differ from each other in morphology, in kinetics and in the molecules involved. Here we show, using a specific caspase inhibitor, that several forms of active death can be discriminated in one model, a lymphoma cell line, exposed to etoposide. IJT58, a human B lymphoma cell line was treated with 10pM etoposide and/or 100 pM Z-VAD-FMK as a general caspase inhibitor, which was given daily. Viability was assessed by trypan blue staining. Cell cycle arid sub-Gl (apoptotic) cell population were measured by flow cytometry after propidium iodide staining. Clonality assay (12 days) was performed in soft agar. HT58 cells exposed to etoposide died by fast apoptosis (at 4 h) dependent on caspase activity but independent of new protein synthesis. More prolonged (3 days) incubation with etoposide resulted in apoptosis, but with a slower rate, that was also sensitive to caspase inhibitor, Z-VAD-FMK. HT58 cells are Fas receptor (FasR) negative, but etoposide treatment induced FasR expression on the first day indicating the possible involvement of FasR mediated signals in cell death. In a third phase (after the 3rd day) a portion of the etoposide treated, Z-VAD-FMK-rescued lymphoma cells died in spite of the presence of fresh caspase inhibitor. The survived cells were arrested in S phase, that may protect cells from engagement to mitotic death in the G2 phase. However, the cells protected by caspase inhibitor against etoposide lost their clonal potential (

AB - Etoposide induces DNA damage that signals for various forms of active call death in various eel! types, that frequently differ from each other in morphology, in kinetics and in the molecules involved. Here we show, using a specific caspase inhibitor, that several forms of active death can be discriminated in one model, a lymphoma cell line, exposed to etoposide. IJT58, a human B lymphoma cell line was treated with 10pM etoposide and/or 100 pM Z-VAD-FMK as a general caspase inhibitor, which was given daily. Viability was assessed by trypan blue staining. Cell cycle arid sub-Gl (apoptotic) cell population were measured by flow cytometry after propidium iodide staining. Clonality assay (12 days) was performed in soft agar. HT58 cells exposed to etoposide died by fast apoptosis (at 4 h) dependent on caspase activity but independent of new protein synthesis. More prolonged (3 days) incubation with etoposide resulted in apoptosis, but with a slower rate, that was also sensitive to caspase inhibitor, Z-VAD-FMK. HT58 cells are Fas receptor (FasR) negative, but etoposide treatment induced FasR expression on the first day indicating the possible involvement of FasR mediated signals in cell death. In a third phase (after the 3rd day) a portion of the etoposide treated, Z-VAD-FMK-rescued lymphoma cells died in spite of the presence of fresh caspase inhibitor. The survived cells were arrested in S phase, that may protect cells from engagement to mitotic death in the G2 phase. However, the cells protected by caspase inhibitor against etoposide lost their clonal potential (

UR - http://www.scopus.com/inward/record.url?scp=84882946655&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84882946655&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84882946655

VL - 43

SP - 94

EP - 99

JO - Magyar Onkologia

JF - Magyar Onkologia

SN - 0025-0244

IS - 2

ER -